Purdue Pharma Authorized to Appeal Judge’s Rejection of Sackler Settlement Plan

A federal judge authorized Purdue Pharma LP and its Sackler family owners to appeal a ruling that threw out their $4.5 billion settlement of thousands of lawsuits linked to the bankrupt company’s OxyContin painkiller and its role in the opioid crisis. Purdue has until Jan. 17 to apply to the Second U.S. Circuit Court of … Read more

Medicare Seeks to Cut Drug Costs for People in Part D Plans

Jan. 7, 2022 — The Biden administration said this week it intends to challenge insurance companies to deliver better service to people enrolled in Medicare, including applying discounts on drugs covered by Part D more directly to their pharmacy costs. The Centers for Medicare and Medicaid Services (CMS) on Thursday unveiled a 360-page proposed rule … Read more

Drug Can Keep Leukemia in Remission for Years in Younger Patients

By Robert PreidtHealthDay Reporter TUESDAY, Dec. 14, 2021 (HealthDay News) — For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46 had more aggressive, unmutated IGHV subtype of … Read more

‘Magic Mushroom’ Drug Edges Toward Mainstream Therapy

By Dennis Thompson HealthDay Reporter MONDAY, Dec. 6, 2021 (HealthDay News) —  Tony Head was depressed and fearing death from stage 4 prostate cancer when, as part of a supervised scientific trial, he took a large dose of the psychedelic agent in “magic mushrooms,” psilocybin. Head donned a mask and headphones to shut out the … Read more

Nawab Malik says NCB wants to take over ‘top five’ drug cases from Maharashtra police, questions motive

Maharashtra minister Nawab Malik on Friday said the NCB has asked the state police’s Anti Narcotics Cell (ANC) to transfer its “top five cases” to the central agency, and questioned the Union government’s intentions. The Narcotics Control Bureau‘s (NCB) letter to the ANC attributed the decision to Union Home Minister Amit Shah, he claimed in … Read more

FDA Generic Drug Program Shows Progress Toward Lowering Costs

Nov. 18, 2021 — At least one generic drug approval – and ideally more than one – is needed to spur competition and reduce the overall cost to consumers taking a particular medication. This is particularly true when a drug is difficult to make or has the potential to only treat a small number of … Read more